A Comparative Clinical Study of Latanoprost and Isopropyl Unoprostone in Japanese Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
暂无分享,去创建一个
M. Araie | A. Negi | H. Abe | H. Mishima | Y. Kitazawa | H. Tsukamoto
[1] Y. Chan,et al. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension. , 2001, American journal of ophthalmology.
[2] R. Susanna,et al. A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension. , 2001, Ophthalmology.
[3] M. Yablonski,et al. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. , 1999, American journal of ophthalmology.
[4] J. Rouland,et al. A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension. , 1999, Current medical research and opinion.
[5] W. C. Stewart,et al. The Effects of Unoprostone Isopropyl 0.12% and Timolol Maleate 0.5% on Diurnal Intraocular Pressure , 1998, Journal of glaucoma.
[6] M. Yablonski,et al. Bunazosin reduces intraocular pressure in rabbits by increasing uveoscleral outflow. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[7] R. Brubaker,et al. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. , 1997, Survey of ophthalmology.
[8] H. Mishima,et al. Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow. , 1997, Survey of ophthalmology.
[9] M. Araie,et al. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. , 1996, Archives of ophthalmology.
[10] L. Bito,et al. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol. , 1996, Archives of ophthalmology.
[11] C. Camras. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. , 1996, Ophthalmology.
[12] J. Stjernschantz,et al. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. , 1996, Ophthalmology.
[13] A. Alm,et al. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. , 1995, Ophthalmology.
[14] B. Sjöquist,et al. Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2a analogue , 1995 .
[15] Y. Goh,et al. Pharmacological characterization of prostaglandin-related ocular hypotensive agents , 1994 .
[16] M. Yablonski,et al. Effects of PhXA41, A New Prostaglandin F2α Analog, on Aqueous Humor Dynamics in Human Eyes , 1993 .
[17] M. Yablonski,et al. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. , 1993, Ophthalmology.
[18] Y. Kitazawa,et al. Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension. , 1993, Japanese journal of ophthalmology.
[19] M. Yablonski,et al. Fluorophotometric study of epinephrine and timolol in human subjects. , 1981, Archives of ophthalmology.
[20] R. Brubaker,et al. Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry. , 1980, Investigative ophthalmology & visual science.